Celldex (CLDX) stock surged as enrollments for a late-stage program for the lead asset barzolvolimab concluded ahead of schedule. Read more here.

Ooops... Something went wrong while loading this page.

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Eberechi Eze is Arsenal's north London derby hero again as they beat Spurs to stretch their lead at the top to five points ...

AI isn’t just helping out with coding — it’s helping complete entire projects at a pace and price-point that would’ve been unthinkable ...